News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Annie Guérin

Articles by Annie Guérin

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer

FDA Approves Narsoplimab for HSCT-Associated Thrombotic Microangiopathy

Developer Submits 510(k) Premarket Notification for SC Infusion System in HER2+ BC

Minority/Medicaid Status Associated With Lower PRO Utilization in Oncology

Integrating Bioimpedance Spectroscopy: Streamlining Early Lymphedema Detection